Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA tissue cell type enrichment"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"
AOAH		ENSG00000136250	"Acyloxyacyl hydrolase"	P28039	7	36512941-36724549	"Enzymes, Metabolic proteins, Predicted secreted proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 43.3;lymphoid tissue: 64.9"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 60.5;Kupffer cells: 93.5;Macrophages: 75.0;Microglial cells: 227.1;monocytes: 89.5;NK-cells: 101.0;T-cells: 48.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 298.5"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"colorectal cancer: 4.1;Leukemia: 6.1;lymphoma: 3.4"	"Breast - T-cells, Lung - NK-cells (Lung), Prostate - T-cells, Stomach - Macrophages, Thyroid - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA021666, HPA026716"	Approved		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to blood"	NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 66: Myeloid cells - Innate immune response"	"Cluster 7: NK-cells - Immune response regulation"	Vesicles	"Endoplasmic reticulum"	"HPA021666: AB_2670799, HPA026716: AB_2671960"	"unprognostic (3.55e-2)"	"unprognostic (4.03e-3)"	"unprognostic (4.45e-2)"	"unprognostic (3.58e-1)"	"unprognostic (6.06e-2)"	"unprognostic (4.78e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.14e-3)"	"unprognostic (5.42e-2)"	"unprognostic (6.02e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.46e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.92e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.35e-1)"
ARHGAP9	"10C, MGC1295"	ENSG00000123329	"Rho GTPase activating protein 9"	Q9BRR9	12	57472264-57488814	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 119.7;lymphoid tissue: 100.7"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 80.3;Early spermatids: 119.5;Hofbauer cells: 50.7;NK-cells: 176.8;Spermatocytes: 78.1;T-cells: 102.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 388.9"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"Leukemia: 35.3;lymphoma: 19.9;Myeloma: 14.7"	"Breast - T-cells, Kidney - T-cells, Lung - NK-cells (Lung), Prostate - T-cells, Testis - Early spermatids, Testis - Late spermatids, Thyroid - T-cells"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA078822			Approved	"Plasma membrane,Cell Junctions"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 66: Myeloid cells - Innate immune response"	"Cluster 7: NK-cells - Immune response regulation"	"Plasma membrane"	"Cell Junctions"	"HPA078822: "	"unprognostic (1.02e-2)"	"unprognostic (4.01e-3)"	"unprognostic (1.91e-2)"	"prognostic favorable (6.61e-5)"	"unprognostic (1.24e-1)"	"unprognostic (2.38e-3)"	"unprognostic (4.79e-2)"	"unprognostic (5.56e-3)"	"unprognostic (1.28e-2)"	"unprognostic (2.80e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.64e-1)"	"prognostic unfavorable (7.90e-9)"	"unprognostic (1.60e-1)"	"unprognostic (6.32e-2)"	"unprognostic (9.13e-2)"	"unprognostic (6.91e-2)"
BTN2A2	"BT2.2, BTF2, BTN2.2"	ENSG00000124508	"Butyrophilin subfamily 2 member A2"	Q8WVV5	6	26383096-26394874	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"granulocytes: 45.1;Langerhans cells: 29.7;Plasma cells: 29.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cancer enhanced"	"Detected in all"		"Myeloma: 72.6"	"Lung - NK-cells (Lung), Thyroid - T-cells"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA051504	Uncertain		Approved	Mitochondria		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 16: Immune cells - Immune response"	"Cluster 44: Myeloma - Humoral immune response"	"Cluster 75: Myeloid cells - Innate immune response"	Mitochondria		"HPA051504: AB_2681510"	"prognostic favorable (1.01e-4)"	"unprognostic (4.93e-3)"	"unprognostic (1.37e-2)"	"unprognostic (6.78e-2)"	"unprognostic (9.26e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.04e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.22e-2)"	"unprognostic (6.67e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.45e-1)"	"unprognostic (6.54e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.36e-3)"
C5orf58		ENSG00000234511	"Chromosome 5 open reading frame 58"	C9J3I9	5	170232447-170252575	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	35	"testis: 216.4"	"Cell type enriched"	"Detected in some"	11	"Spermatocytes: 1206.9"	"Cancer enhanced"	"Detected in single"		"testis cancer: 1.3"	"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cancer enhanced"	"Detected in many"		"Myeloma: 8.1"	"Lung - NK-cells (Lung), Testis - Early spermatids, Thyroid - T-cells"					"Not detected"	"Not detected"									NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 44: Myeloma - Humoral immune response"	"Cluster 31: Spermatocytes - Spermatogenesis"				"unprognostic (9.24e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.61e-2)"	"unprognostic (5.55e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.35e-1)"	"unprognostic (5.33e-6)"	"unprognostic (1.01e-1)"	"unprognostic (5.61e-2)"	"unprognostic (8.48e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.29e-10)"	"unprognostic (4.83e-3)"	"unprognostic (5.45e-2)"	"unprognostic (3.94e-2)"	"unprognostic (8.27e-2)"
CD244	"2B4, NAIL, NKR2B4, Nmrk, SLAMF4"	ENSG00000122223	"CD244 molecule"	Q9BZW8	1	160830160-160862887	"CD markers, Plasma proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 10.0;lymphoid tissue: 16.8"	"Cell type enhanced"	"Detected in some"		"Kupffer cells: 12.7;Macrophages: 7.4;monocytes: 15.7;NK-cells: 40.4;T-cells: 18.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in many"	4	"basophil: 472.1"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 472.1"	"Cancer enriched"	"Detected in some"	14	"Leukemia: 15.0"	"Adipose subcutaneous - T-cells, Adipose visceral - Mesothelial cells, Breast - T-cells, Heart muscle - T-cells, Kidney - T-cells, Lung - NK-cells (Lung), Prostate - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA		280000	"Cluster 46: Basophils - DNA binding"	"Cluster 2: Immune cells - Immune response"	"Cluster 66: Myeloid cells - Innate immune response"	"Cluster 7: NK-cells - Immune response regulation"				"unprognostic (6.11e-3)"	"unprognostic (1.54e-2)"	"unprognostic (1.85e-2)"	"unprognostic (6.95e-6)"	"unprognostic (5.79e-2)"	"unprognostic (1.43e-4)"	"unprognostic (1.93e-2)"	"unprognostic (7.36e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.32e-1)"	"unprognostic (5.40e-4)"	"unprognostic (1.71e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.79e-1)"
CD7	"GP40, LEU-9, Tp40, TP41"	ENSG00000173762	"CD7 molecule"	P09564	17	82314868-82317608	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 28.6;lymphoid tissue: 53.7"	"Group enriched"	"Detected in many"	14	"NK-cells: 1172.5;T-cells: 544.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 231.5"	"Group enriched"	"Detected in many"	22	"NK-cells: 231.5;T-cells: 71.5"	"Group enriched"	"Detected in some"	7	"Leukemia: 49.8;liver cancer: 16.2;Myeloma: 24.1"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Heart muscle - T-cells, Liver - NK-cells (Liver), Lung - NK-cells (Lung), Pancreas - T-cells, Prostate - T-cells, Thyroid - T-cells"	"Region enhanced"	"Detected in some"		"cerebral cortex: 3.2"	"Not detected"	"Not detected"			"CAB002594, HPA039079"	Enhanced					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 7: NK-cells - Immune response regulation"			"CAB002594: , HPA039079: AB_2676337"	"unprognostic (3.14e-3)"	"prognostic favorable (5.51e-4)"	"unprognostic (1.89e-2)"	"prognostic favorable (2.03e-5)"	"unprognostic (7.69e-3)"	"unprognostic (1.09e-3)"	"unprognostic (3.28e-2)"	"unprognostic (1.34e-1)"	"prognostic favorable (2.69e-4)"	"unprognostic (3.16e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.24e-1)"	"prognostic unfavorable (7.75e-11)"	"unprognostic (4.69e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.55e-3)"
CEACAM3	"CD66d, CGM1"	ENSG00000170956	"CEA cell adhesion molecule 3"	P40198	19	41796587-41811554	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"bone marrow: 44.3"	"Cell type enriched"	"Detected in some"	14	"Paneth cells: 48.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in many"	6	"neutrophil: 289.3"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 289.3"	"Not detected"	"Not detected"			"Adipose visceral - Neutrophils, Heart muscle - Neutrophils, Lung - NK-cells (Lung), Stomach - Neutrophils, Thyroid - Neutrophils"									HPA011041	Approved					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 10: Ovarian & Endometrial cancers - Unknown function"	"Cluster 33: Macrophages - Degranulation"			"HPA011041: AB_1078481"	"unprognostic (1.60e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.95e-2)"	"unprognostic (2.19e-1)"	"unprognostic (8.09e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.62e-1)"	"unprognostic (8.07e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.68e-2)"	"unprognostic (8.44e-2)"	"unprognostic (2.83e-1)"
CEP78	"C9orf81, FLJ12643"	ENSG00000148019	"Centrosomal protein 78"	Q5JTW2	9	78236062-78279690	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Cone-rod dystrophy, Deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 70.7;NK-cells: 216.7;Spermatocytes: 79.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 39.1"	"Group enriched"	"Detected in many"	5	"NK-cells: 39.1;T-cells: 18.3"	"Cancer enhanced"	"Detected in all"		"Rhabdoid: 68.3"	"Lung - NK-cells (Lung), Testis - Spermatocytes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048846	Approved					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 34: Rabdoid cancer - Embryonic development"	"Cluster 7: NK-cells - Immune response regulation"			"HPA048846: AB_2680537"	"unprognostic (4.62e-1)"	"unprognostic (6.33e-3)"	"unprognostic (2.87e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.36e-2)"	"unprognostic (5.13e-4)"	"unprognostic (6.75e-2)"	"unprognostic (8.48e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.38e-2)"	"unprognostic (7.03e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.27e-3)"	"unprognostic (4.93e-1)"	"unprognostic (1.18e-3)"	"unprognostic (3.34e-1)"
CERKL	RP26	ENSG00000188452	"Ceramide kinase like"	Q49MI3	2	181536672-181680665	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 17.1;retina: 16.6"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 19.0;Endometrial ciliated cells: 44.0;Respiratory ciliated cells: 25.3;Rod photoreceptor cells: 26.5"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	5	"cerebellum: 9.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"lung cancer: 2.7;Neuroblastoma: 2.5"	"Adipose visceral - T-cells, Lung - NK-cells (Lung), Prostate - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebellum: 14.5"	"HPA035443, HPA035444, HPA043203"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 7: Neuronal cell lines - Stereocilium"	"Cluster 56: Ciliated cells - Cilium assembly"	"Nucleoplasm, Cytosol"		"HPA035443: AB_2674625, HPA035444: AB_10672093, HPA043203: "	"unprognostic (7.52e-3)"	"unprognostic (6.13e-3)"	"unprognostic (2.09e-1)"	"unprognostic (3.92e-3)"	"unprognostic (4.46e-1)"	"unprognostic (2.71e-3)"	"unprognostic (2.59e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.27e-1)"	"prognostic favorable (5.25e-4)"	"unprognostic (4.54e-2)"	"prognostic unfavorable (2.10e-4)"	"unprognostic (1.37e-1)"	"unprognostic (3.65e-2)"	"unprognostic (3.07e-2)"	"unprognostic (8.45e-2)"
DGKK		ENSG00000274588	"Diacylglycerol kinase kappa"	Q5KSL6	X	50365409-50470825	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	29	"adrenal gland: 3.4;brain: 12.2;pituitary gland: 6.1"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 1.3;Inhibitory neurons: 1.5;Late spermatids: 2.3;NK-cells: 6.9;Oligodendrocyte precursor cells: 1.9"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"thalamus: 12.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	18	"Bone cancer: 1.5;liver cancer: 4.5;Neuroblastoma: 3.7;testis cancer: 1.6"	"Lung - NK-cells (Lung)"	"Region enhanced"	"Detected in many"		"hypothalamus: 19.8"	"Low region specificity"	"Detected in some"									NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 35: Liver cancer - Metabolism"	"Cluster 7: NK-cells - Immune response regulation"				"unprognostic (3.99e-1)"		"unprognostic (1.18e-1)"	"unprognostic (4.18e-3)"	"unprognostic (1.23e-1)"		"unprognostic (5.83e-3)"	"unprognostic (9.58e-2)"		"unprognostic (2.41e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.28e-3)"	"unprognostic (3.89e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.49e-2)"	"unprognostic (4.64e-3)"
EOMES	TBR2	ENSG00000163508	Eomesodermin	O95936	3	27715949-27722711	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Adaptive immunity, Differentiation, Gastrulation, Immunity, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 8.4;lymphoid tissue: 15.0"	"Group enriched"	"Detected in some"	4	"NK-cells: 79.7;T-cells: 32.0"	"Cancer enhanced"	"Detected in many"		"testis cancer: 5.8"	"Region enriched"	"Detected in single"	13	"cerebellum: 8.4"	"Group enriched"	"Detected in many"	7	"gdT-cell: 16.5;MAIT T-cell: 26.2;memory CD8 T-cell: 19.5;naive CD8 T-cell: 11.9;NK-cell: 33.0"	"Group enriched"	"Detected in many"	107	"NK-cells: 33.0;T-cells: 26.2"	"Group enriched"	"Detected in some"	6	"lymphoma: 4.7;Rhabdoid: 8.2"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Heart muscle - T-cells, Kidney - T-cells, Liver - NK-cells (Liver), Lung - NK-cells (Lung), Thyroid - T-cells"	"Region enriched"	"Detected in many"	8	"olfactory bulb: 77.5"	"Group enriched"	"Detected in some"	27	"cerebellum: 30.2;olfactory bulb: 12.7"	HPA028896	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 50: L-1236 & L-428 - Unknown function"	"Cluster 7: NK-cells - Immune response regulation"	Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA028896: AB_10601370"	"unprognostic (1.53e-4)"	"unprognostic (5.95e-3)"	"unprognostic (3.01e-2)"	"unprognostic (1.60e-4)"	"unprognostic (4.13e-2)"	"unprognostic (9.63e-4)"	"unprognostic (4.29e-4)"	"unprognostic (3.14e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.82e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (9.45e-6)"	"unprognostic (1.61e-1)"	"unprognostic (5.09e-1)"	"unprognostic (6.32e-3)"	"unprognostic (1.49e-2)"
FASLG	"APT1LG1, CD178, FasL, TNFSF6"	ENSG00000117560	"Fas ligand"	P48023	1	172659103-172666876	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	"Apoptosis, Transcription, Transcription regulation"	"Cytokine, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 5.7"	"Group enriched"	"Detected in some"	7	"NK-cells: 72.9;T-cells: 26.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 58.1"	"Group enriched"	"Detected in many"	9	"NK-cells: 41.5;T-cells: 58.1"	"Cancer enhanced"	"Detected in single"		"colorectal cancer: 1.3"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Heart muscle - T-cells, Kidney - T-cells, Liver - NK-cells (Liver), Lung - NK-cells (Lung), Prostate - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA054959	Approved				"Secreted to blood"	NA	NA	73600		"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 2: DU4475 - Unknown function"	"Cluster 7: NK-cells - Immune response regulation"			"HPA054959: AB_2682650"	"unprognostic (1.09e-3)"	"unprognostic (1.41e-2)"	"unprognostic (8.69e-2)"	"unprognostic (1.54e-7)"	"unprognostic (3.29e-1)"	"unprognostic (2.23e-3)"	"unprognostic (5.44e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.67e-2)"	"unprognostic (4.76e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (1.59e-6)"	"unprognostic (3.49e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.15e-2)"	"unprognostic (3.82e-3)"
FCRL3	"CD307c, FCRH3, IFGP3, IRTA3, SPAP2, SPAP2a, SPAP2b, SPAP2c, SPAP2d, SPAP2e"	ENSG00000160856	"Fc receptor like 3"	Q96P31	1	157674321-157700769	"CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"lymphoid tissue: 49.5"	"Cell type enhanced"	"Detected in some"		"B-cells: 46.2;Late spermatids: 10.8;NK-cells: 29.1;T-cells: 9.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"naive B-cell: 35.3"	"Group enriched"	"Detected in many"	54	"B-cells: 35.3;NK-cells: 20.4;T-cells: 19.0"	"Cancer enriched"	"Detected in single"	67	"lymphoma: 14.1"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Heart muscle - T-cells, Kidney - T-cells, Liver - NK-cells (Liver), Lung - NK-cells (Lung), Testis - Late spermatids"					"Low region specificity"	"Detected in some"			HPA048022	Enhanced					NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 62: B-cells - B-cell activation"			"HPA048022: AB_2732541"	"unprognostic (6.73e-3)"	"unprognostic (5.06e-4)"	"unprognostic (1.13e-2)"	"unprognostic (2.08e-4)"	"unprognostic (3.86e-1)"	"unprognostic (1.74e-5)"	"unprognostic (1.09e-2)"	"unprognostic (4.29e-3)"	"unprognostic (3.69e-3)"	"unprognostic (2.46e-4)"	"unprognostic (1.13e-1)"	"unprognostic (2.55e-2)"	"unprognostic (2.01e-4)"	"unprognostic (1.55e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.21e-1)"	"unprognostic (6.69e-2)"
GBP1		ENSG00000117228	"Guanylate binding protein 1"	P32455	1	89051882-89065360	"Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Immunity"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 88.0"	"Cell type enhanced"	"Detected in many"		"monocytes: 96.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Lung - NK-cells (Lung)"									CAB015450	Approved				"Intracellular and membrane"	NA	NA		110000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 64: Macrophages - Immune response"	"Cluster 30: Non-specific - Antiviral immune response"	"Cluster 19: Macrophages - Innate immune response"			"CAB015450: AB_2109333"	"unprognostic (3.43e-2)"	"unprognostic (1.82e-2)"	"prognostic favorable (8.32e-4)"	"unprognostic (9.56e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.10e-1)"	"unprognostic (9.50e-2)"	"unprognostic (3.64e-2)"	"unprognostic (7.67e-2)"	"prognostic favorable (5.04e-4)"	"unprognostic (8.36e-3)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (5.12e-9)"	"unprognostic (4.67e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.23e-2)"	"unprognostic (2.01e-3)"
GZMB	"CCPI, CGL-1, CGL1, CSP-B, CSPB, CTLA1, CTSGL1, HLP, SECT"	ENSG00000100453	"Granzyme B"	P10144	14	24630954-24634267	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Cytolysis"	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 68.2;lymphoid tissue: 37.1"	"Group enriched"	"Detected in many"	6	"dendritic cells: 2884.6;NK-cells: 1948.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"plasmacytoid DC: 6765.2"	"Lineage enriched"	"Detected in all"	5	"dendritic cells: 6765.2"	"Cancer enriched"	"Detected in some"	51	"lymphoma: 378.9"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Heart muscle - T-cells, Liver - NK-cells (Liver), Lung - NK-cells (Lung), Prostate - T-cells, Skin - T-cells, Thyroid - T-cells"									"CAB000376, HPA003418"	Enhanced				"Secreted to blood"	NA	NA	2170		"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 54: Lymphoma - Cytokine signaling"	"Cluster 7: NK-cells - Immune response regulation"			"CAB000376: AB_323716, HPA003418: AB_1079020"	"prognostic favorable (7.27e-4)"	"unprognostic (2.82e-3)"	"unprognostic (8.54e-2)"	"prognostic favorable (1.58e-5)"	"unprognostic (2.07e-3)"	"unprognostic (1.48e-3)"	"unprognostic (4.43e-2)"	"unprognostic (8.25e-2)"	"unprognostic (3.70e-2)"	"unprognostic (3.05e-3)"	"unprognostic (4.26e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (1.10e-7)"	"unprognostic (1.24e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.71e-3)"
HCAR2	"GPR109A, HCA2, HM74A, NIACR1, Puma-g, PUMAG"	ENSG00000182782	"Hydroxycarboxylic acid receptor 2"	Q8TDS4	12	122701293-122703357	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"	Apoptosis	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 40.8;skin 1: 30.2"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 56.3;Basal prostatic cells: 156.2;Basal respiratory cells: 47.4;Basal squamous epithelial cells: 99.7;Langerhans cells: 142.8;Suprabasal keratinocytes: 66.4"	"Group enriched"	"Detected in many"	8	"cervical cancer: 12.6;head and neck cancer: 16.1;lung cancer: 6.4;urothelial cancer: 9.2"	"Region enriched"	"Detected in some"	5	"cerebral cortex: 5.9"	"Immune cell enriched"	"Detected in many"	5	"neutrophil: 176.7"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 176.7"	"Cancer enhanced"	"Detected in many"		"Bladder cancer: 20.9;Esophageal cancer: 22.9;head and neck cancer: 50.1"	"Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Breast - Adipocytes (Breast), Lung - NK-cells (Lung), Skin - Keratinocyte (other), Testis - Late spermatids"									HPA028660	Approved		Supported	"Cell Junctions"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 60: Keratinocytes - Epithelial cell function"	"Cluster 22: Squamous epithelial cells - Keratinization"	"Cell Junctions"		"HPA028660: AB_10602139"	"unprognostic (5.43e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.05e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.33e-3)"	"unprognostic (7.26e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.77e-2)"	"unprognostic (7.10e-2)"	"unprognostic (7.33e-2)"	"unprognostic (4.83e-4)"	"unprognostic (5.76e-2)"	"unprognostic (5.07e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.63e-2)"
HCAR3	"GPR109B, HCA3, HM74"	ENSG00000255398	"Hydroxycarboxylic acid receptor 3"	P49019	12	122714756-122716811	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 27.4;esophagus: 16.8;lymphoid tissue: 19.6;skin 1: 17.4"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 79.7;Basal prostatic cells: 192.2;Basal respiratory cells: 54.1;Basal squamous epithelial cells: 139.8;Langerhans cells: 72.1;Squamous epithelial cells: 45.9;Suprabasal keratinocytes: 87.8"	"Group enriched"	"Detected in some"	4	"cervical cancer: 2.1;head and neck cancer: 2.5;lung cancer: 1.0;urothelial cancer: 1.9"	"Region enriched"	"Detected in single"	5	"cerebral cortex: 4.7"	"Group enriched"	"Detected in many"	6	"basophil: 58.6;neutrophil: 177.2;non-classical monocyte: 84.4"	"Group enriched"	"Detected in many"	50	"granulocytes: 177.2;monocytes: 84.4"	"Group enriched"	"Detected in some"	5	"Bladder cancer: 7.1;cervical cancer: 3.9;Esophageal cancer: 4.9;Gallbladder cancer: 6.6;head and neck cancer: 12.4"	"Adipose visceral - Adipocytes (Visceral), Lung - NK-cells (Lung), Prostate - Urothelial cells, Skin - Keratinocyte (other)"									HPA028660	Approved		Approved	"Cell Junctions"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 60: Keratinocytes - Epithelial cell function"	"Cluster 22: Squamous epithelial cells - Keratinization"	"Cell Junctions"		"HPA028660: AB_10602139"	"unprognostic (2.32e-1)"	"unprognostic (5.82e-2)"	"unprognostic (8.23e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.17e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.60e-1)"	"unprognostic (6.29e-2)"	"unprognostic (9.87e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.16e-1)"	"unprognostic (9.28e-2)"
HLA-F		ENSG00000204642	"Major histocompatibility complex, class I, F"	P30511	6	29722775-29738528	"Plasma proteins, Predicted membrane proteins"	Immunity			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 188.3"	"Cell type enhanced"	"Detected in many"		"monocytes: 207.9;NK-cells: 382.8;Proximal enterocytes: 325.6;T-cells: 191.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Adipose visceral - T-cells, Lung - NK-cells (Lung), Prostate - T-cells, Thyroid - T-cells"															NA	NA		15000000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 30: Non-specific - Antiviral immune response"	"Cluster 7: NK-cells - Immune response regulation"				"unprognostic (3.07e-3)"	"unprognostic (5.16e-2)"	"unprognostic (3.05e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.82e-1)"	"unprognostic (4.99e-2)"	"unprognostic (2.68e-1)"	"unprognostic (4.21e-3)"	"unprognostic (2.43e-3)"	"unprognostic (3.21e-2)"	"unprognostic (2.57e-1)"	"prognostic unfavorable (2.67e-4)"	"unprognostic (1.26e-1)"	"unprognostic (2.95e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.30e-2)"
HSH2D	"ALX, FLJ14886, HSH2"	ENSG00000196684	"Hematopoietic SH2 domain containing"	Q96JZ2	19	16134028-16158575	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 47.0;lymphoid tissue: 37.7"	"Cell type enhanced"	"Detected in many"		"B-cells: 66.5;Gastric mucus-secreting cells: 39.9;NK-cells: 140.1;Plasma cells: 110.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"basophil: 232.1"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Leukemia: 50.3;lymphoma: 32.9;Myeloma: 30.5"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Heart muscle - T-cells, Lung - NK-cells (Lung), Thyroid - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA036616			Approved	"Plasma membrane,Focal adhesion sites,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 2: Immune cells - Immune response"	"Cluster 66: Myeloid cells - Innate immune response"	"Cluster 40: Plasma cells - Humoral immune response"	"Plasma membrane"	"Focal adhesion sites, Cytosol"	"HPA036616: AB_10671962"	"unprognostic (1.69e-1)"	"unprognostic (2.97e-2)"	"prognostic unfavorable (9.46e-6)"	"unprognostic (1.06e-1)"	"unprognostic (5.50e-3)"	"unprognostic (5.21e-3)"	"unprognostic (9.35e-2)"	"unprognostic (4.78e-2)"	"unprognostic (4.21e-3)"	"unprognostic (9.96e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.22e-2)"	"prognostic unfavorable (6.49e-6)"	"unprognostic (9.17e-3)"	"unprognostic (6.18e-2)"	"unprognostic (3.21e-2)"	"prognostic favorable (3.47e-5)"
KLRB1	"CD161, CLEC5B, hNKR-P1A, NKR, NKR-P1, NKR-P1A"	ENSG00000111796	"Killer cell lectin like receptor B1"	Q12918	12	9594551-9607916	"CD markers, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 47.4;lymphoid tissue: 36.4"	"Group enriched"	"Detected in many"	7	"NK-cells: 1508.8;T-cells: 767.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in all"		"MAIT T-cell: 2177.1"	"Group enriched"	"Detected in all"	140	"NK-cells: 756.7;T-cells: 2177.1"	"Not detected"	"Not detected"			"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Heart muscle - T-cells, Kidney - T-cells, Liver - NK-cells (Liver), Lung - NK-cells (Lung), Pancreas - T-cells, Prostate - T-cells, Thyroid - T-cells"					"Not detected"	"Not detected"			HPA039113	Approved		Uncertain	Nucleoplasm,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 7: NK-cells - Immune response regulation"	Nucleoplasm	Cytosol	"HPA039113: AB_10674979"	"prognostic favorable (3.51e-5)"	"unprognostic (1.23e-3)"	"unprognostic (7.03e-3)"	"prognostic favorable (1.42e-5)"	"unprognostic (1.69e-1)"	"prognostic favorable (6.99e-5)"	"unprognostic (1.54e-3)"	"unprognostic (7.15e-3)"	"unprognostic (4.12e-1)"	"unprognostic (8.23e-3)"	"unprognostic (3.57e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.34e-1)"	"prognostic favorable (5.61e-4)"	"unprognostic (1.17e-2)"
KLRC3	NKG2-E	ENSG00000205810	"Killer cell lectin like receptor C3"	Q07444	12	10412315-10420595	"Predicted membrane proteins"		Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 1.9;brain: 2.1;lymphoid tissue: 4.0"	"Group enriched"	"Detected in some"	5	"NK-cells: 17.4;Oligodendrocyte precursor cells: 34.7;T-cells: 9.4"	"Cancer enriched"	"Detected in single"	9	"glioma: 0.6"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	6	"NK-cell: 63.1"	"Lineage enriched"	"Detected in many"	6	"NK-cells: 63.1"	"Cancer enhanced"	"Detected in some"		"lymphoma: 6.8;thyroid cancer: 5.5"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Lung - NK-cells (Lung), Prostate - T-cells, Thyroid - T-cells"									"HPA039910, HPA062570"	Approved		Uncertain	Vesicles		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 2: T-cells - T-cell receptor"	Vesicles		"HPA039910: , HPA062570: AB_2684795"	"unprognostic (8.92e-4)"	"unprognostic (4.47e-2)"	"unprognostic (2.03e-2)"		"unprognostic (1.32e-1)"	"unprognostic (5.07e-3)"		"unprognostic (2.48e-1)"	"unprognostic (3.22e-1)"		"unprognostic (9.12e-2)"		"unprognostic (3.52e-3)"	"unprognostic (3.09e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.15e-1)"	
KRT72	"K6irs, K6IRS2, KRT6, KRT6IRS2"	ENSG00000170486	"Keratin 72"	Q14CN4	12	52585589-52601538	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"skin 1: 10.5;testis: 23.7"	"Group enriched"	"Detected in some"	6	"Early spermatids: 24.6;Late spermatids: 69.0;Spermatocytes: 45.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	17	"Leukemia: 2.4"	"Lung - NK-cells (Lung), Testis - Early spermatids"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA065523	Enhanced					NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 42: Spermatocytes & Spermatids - Spermatogenesis"			"HPA065523: AB_2685504"	"unprognostic (3.36e-1)"	"unprognostic (7.20e-2)"				"unprognostic (3.41e-2)"		"unprognostic (1.02e-1)"			"unprognostic (6.97e-2)"	"unprognostic (4.38e-3)"	"unprognostic (4.82e-3)"	"unprognostic (2.88e-2)"	"unprognostic (9.16e-2)"		"unprognostic (1.19e-1)"
KRT73	"K6IRS3, KRT6IRS3"	ENSG00000186049	"Keratin 73"	Q86Y46	12	52607570-52618559	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"skin 1: 17.0"	"Cell type enriched"	"Detected in some"	4	"NK-cells: 4.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"naive CD4 T-cell: 8.8;naive CD8 T-cell: 3.1"	"Lineage enriched"	"Detected in single"	13	"T-cells: 8.8"	"Cancer enriched"	"Detected in single"	10	"Leukemia: 1.8"	"Lung - NK-cells (Lung), Skin - Inner root sheath cells"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA044031	Enhanced					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 61: Skin - Cornification"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 7: NK-cells - Immune response regulation"			"HPA044031: AB_10963434"		"unprognostic (2.23e-3)"				"unprognostic (6.54e-2)"					"unprognostic (3.05e-1)"	"unprognostic (2.12e-3)"	"unprognostic (2.11e-3)"		"unprognostic (4.94e-1)"		
LIM2	"MP17, MP19"	ENSG00000105370	"Lens intrinsic membrane protein 2"	P55344	19	51379909-51387974	"Disease related genes, Human disease related genes, Predicted membrane proteins"		"Eye lens protein"	"Cataract, Disease variant"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	6	"NK-cells: 11.8"	"Cancer enriched"	"Detected in single"	40	"testis cancer: 18.3"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	7	"gdT-cell: 11.3"	"Lineage enriched"	"Detected in many"	7	"T-cells: 11.3"	"Cancer enriched"	"Detected in single"	6	"Sarcoma: 1.6"	"Lung - NK-cells (Lung)"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"		"Cluster 27: TE 441.T - Unknown function"	"Cluster 7: NK-cells - Immune response regulation"									"unprognostic (5.25e-2)"							"unprognostic (1.09e-3)"		"unprognostic (1.21e-1)"		
MX2	MXB	ENSG00000183486	"MX dynamin like GTPase 2"	P20592	21	41361999-41409393	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Antiviral defense, Immunity, Innate immunity, mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 30.4"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 47.9;Gastric mucus-secreting cells: 42.9;Kupffer cells: 44.8;Langerhans cells: 38.0;Macrophages: 49.1;monocytes: 117.9;Schwann cells: 47.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in all"	4	"neutrophil: 150.8"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 150.8"	"Low cancer specificity"	"Detected in many"			"Colon - Enteric glia cells, Lung - NK-cells (Lung)"					"Low region specificity"	"Detected in all"			HPA030235	Uncertain					NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 30: Non-specific - Antiviral immune response"	"Cluster 33: Macrophages - Degranulation"			"HPA030235: AB_10601970"	"unprognostic (1.88e-1)"	"unprognostic (2.26e-1)"	"unprognostic (7.90e-3)"	"prognostic unfavorable (3.71e-5)"	"unprognostic (2.50e-1)"	"unprognostic (2.30e-1)"	"unprognostic (7.77e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.63e-1)"	"unprognostic (6.64e-2)"	"unprognostic (2.01e-2)"	"unprognostic (9.48e-2)"	"unprognostic (3.38e-14)"	"unprognostic (6.31e-2)"	"unprognostic (1.59e-3)"	"unprognostic (5.61e-2)"	"unprognostic (1.16e-2)"
MYBL1	"A-myb, AMYB"	ENSG00000185697	"MYB proto-oncogene like 1"	P10243	8	66562175-66614247	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 20.1;testis: 11.8"	"Cell type enhanced"	"Detected in many"		"NK-cells: 185.7;Spermatocytes: 33.2;T-cells: 78.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 1.9;MAIT T-cell: 1.3"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.9"	"Low cancer specificity"	"Detected in all"			"Adipose visceral - T-cells, Kidney - T-cells, Liver - NK-cells (Liver), Lung - NK-cells (Lung), Testis - Early spermatids, Testis - Spermatocytes, Thyroid - T-cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA008791	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 64: Lymphoma - Humoral immune response"	"Cluster 1: T-cells - Immune response"	Nucleoplasm		"HPA008791: AB_1078540"	"unprognostic (1.11e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.57e-1)"	"unprognostic (7.23e-4)"	"unprognostic (2.26e-1)"	"unprognostic (1.89e-2)"	"unprognostic (6.67e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.78e-2)"	"unprognostic (1.13e-2)"	"unprognostic (3.74e-3)"	"prognostic unfavorable (2.03e-8)"	"unprognostic (2.04e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.87e-2)"
NCR3	"1C7, CD337, LY117, NKp30"	ENSG00000204475	"Natural cytotoxicity triggering receptor 3"	O14931	6	31588895-31593006	"CD markers, Predicted membrane proteins"	Immunity	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"bone marrow: 4.0;intestine: 5.6;lymphoid tissue: 16.1"	"Group enriched"	"Detected in some"	12	"B-cells: 46.1;NK-cells: 143.8;T-cells: 50.5"	"Cancer enhanced"	"Detected in many"		"testis cancer: 2.6"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 274.3"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	21	"Leukemia: 2.2;lymphoma: 2.0"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Colon - T-cells, Heart muscle - T-cells, Lung - NK-cells (Lung), Thyroid - T-cells"					"Low region specificity"	"Detected in many"									NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 7: NK-cells - Immune response regulation"				"unprognostic (3.99e-3)"	"unprognostic (9.23e-4)"	"unprognostic (1.23e-3)"	"unprognostic (2.49e-4)"	"unprognostic (2.15e-1)"	"unprognostic (2.57e-4)"	"unprognostic (5.99e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.40e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.21e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.17e-2)"	"unprognostic (1.43e-1)"
NOD2	"BLAU, CARD15, CD, CLR16.3, IBD1, NLRC2, PSORAS1"	ENSG00000167207	"Nucleotide binding oligomerization domain containing 2"	Q9HC29	16	50693588-50734041	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins"	"Immunity, Innate immunity"		"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 13.6;esophagus: 11.7;skin 1: 14.4;vagina: 12.3"	"Cell type enhanced"	"Detected in some"		"Hofbauer cells: 9.9;Kupffer cells: 15.1;Langerhans cells: 30.5;Macrophages: 15.2;monocytes: 25.7;Suprabasal keratinocytes: 15.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"classical monocyte: 23.0;eosinophil: 6.0;intermediate monocyte: 13.1;myeloid DC: 21.3;neutrophil: 10.5;non-classical monocyte: 9.0"	"Group enriched"	"Detected in many"	5	"dendritic cells: 21.3;granulocytes: 10.5;monocytes: 23.0"	"Cancer enhanced"	"Detected in some"		"lymphoma: 3.9"	"Adipose visceral - Macrophages, Lung - NK-cells (Lung), Skin - Keratinocyte (other)"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA041985, HPA054494"	Enhanced		Supported	"Golgi apparatus,Cytosol"		No	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 54: Lymphoma - Cytokine signaling"	"Cluster 75: Myeloid cells - Innate immune response"	"Golgi apparatus, Cytosol"		"HPA041985: AB_2677780, HPA054494: AB_2682505"	"unprognostic (1.01e-1)"	"unprognostic (4.38e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.02e-3)"	"unprognostic (9.91e-3)"	"unprognostic (5.84e-2)"	"unprognostic (5.90e-3)"	"unprognostic (1.23e-1)"	"unprognostic (4.17e-1)"	"unprognostic (3.88e-2)"	"unprognostic (6.94e-3)"	"unprognostic (1.48e-2)"	"unprognostic (2.31e-9)"	"unprognostic (4.38e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.13e-1)"
PRF1	"HPLH2, P1, PFP"	ENSG00000180644	"Perforin 1"	P14222	10	70597348-70602759	"Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	Cytolysis		"Cancer-related genes, Disease variant, Familial hemophagocytic lymphohistiocytosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 28.6;lung: 16.5;lymphoid tissue: 49.4"	"Cell type enriched"	"Detected in some"	4	"NK-cells: 1120.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"gdT-cell: 900.4;MAIT T-cell: 628.8;memory CD8 T-cell: 499.1;naive CD8 T-cell: 313.0;NK-cell: 656.8"	"Group enriched"	"Detected in all"	50	"NK-cells: 656.8;T-cells: 900.4"	"Cancer enriched"	"Detected in some"	7	"lymphoma: 61.8"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Heart muscle - T-cells, Lung - NK-cells (Lung), Pancreas - T-cells, Prostate - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB002436, HPA037940"	Approved		Approved	Cytosol	"Intracellular and membrane"	NA	NA		2100000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 54: Lymphoma - Cytokine signaling"	"Cluster 7: NK-cells - Immune response regulation"	Cytosol		"CAB002436: AB_563955, HPA037940: AB_2675747"	"unprognostic (6.11e-3)"	"unprognostic (1.26e-2)"	"unprognostic (1.71e-1)"	"prognostic favorable (2.09e-4)"	"unprognostic (1.87e-2)"	"prognostic favorable (3.54e-4)"	"unprognostic (6.98e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.44e-3)"	"unprognostic (1.69e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (1.08e-5)"	"unprognostic (7.38e-2)"	"unprognostic (2.70e-1)"	"unprognostic (7.97e-3)"	"unprognostic (5.22e-3)"
PTPRC	"CD45, GP180, LCA, T200"	ENSG00000081237	"Protein tyrosine phosphatase receptor type C"	P08575	1	198638457-198757476	"Cancer-related genes, CD markers, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction"	"Hydrolase, Protein phosphatase"	"Cancer-related genes, Disease variant, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 208.6;lymphoid tissue: 329.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 506.7;Kupffer cells: 464.5;Macrophages: 507.9;monocytes: 1400.2;NK-cells: 1356.4;T-cells: 1034.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"Leukemia: 117.5;lymphoma: 158.9"	"Adipose visceral - T-cells, Breast - T-cells, Kidney - T-cells, Lung - NK-cells (Lung), Skin - T-cells, Thyroid - T-cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB000052, HPA000440, CAB002800, CAB056154, CAB068221"	Enhanced		Uncertain	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		24000000	"Cluster 14: Monocytes - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 1: T-cells - Immune response"	"Nucleoplasm, Vesicles"		"CAB000052: AB_2314143, CAB002800: AB_2237910, CAB056154: AB_2665572, CAB068221: AB_2665571, HPA000440: AB_611377"	"unprognostic (1.51e-2)"	"unprognostic (1.24e-2)"	"unprognostic (5.10e-3)"	"unprognostic (2.33e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.40e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.18e-2)"	"unprognostic (8.08e-2)"	"unprognostic (3.95e-1)"	"prognostic unfavorable (2.42e-4)"	"unprognostic (2.31e-1)"	"unprognostic (3.43e-2)"	"unprognostic (6.41e-2)"	"unprognostic (7.06e-2)"
PYHIN1	"IFIX, MGC23885"	ENSG00000163564	"Pyrin and HIN domain family member 1"	Q6K0P9	1	158930796-158977059	"Predicted intracellular proteins"	"Cell cycle"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 23.1"	"Group enriched"	"Detected in some"	12	"NK-cells: 289.6;T-cells: 96.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	4	"gdT-cell: 97.3;MAIT T-cell: 56.3;memory CD4 T-cell: 40.8;memory CD8 T-cell: 74.7;naive CD8 T-cell: 45.1;NK-cell: 36.8;T-reg: 67.3"	"Group enriched"	"Detected in many"	5	"NK-cells: 36.8;T-cells: 97.3"	"Cancer enriched"	"Detected in some"	5	"lymphoma: 13.8"	"Adipose visceral - T-cells, Colon - T-cells, Heart muscle - T-cells, Kidney - T-cells, Lung - NK-cells (Lung), Prostate - T-cells, Thyroid - T-cells"									"HPA051224, HPA055373"	Enhanced		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 7: NK-cells - Immune response regulation"	Nucleoli	Nucleoplasm	"HPA051224: AB_2681394, HPA055373: "	"unprognostic (1.64e-3)"	"unprognostic (1.75e-3)"	"unprognostic (2.93e-3)"	"unprognostic (2.64e-3)"	"unprognostic (3.99e-2)"	"unprognostic (3.57e-3)"	"unprognostic (2.44e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.47e-3)"	"unprognostic (3.94e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.70e-6)"	"unprognostic (1.83e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.76e-2)"	"unprognostic (4.45e-3)"
SAMD3	"bA73O6.2, FLJ34032"	ENSG00000164483	"Sterile alpha motif domain containing 3"	Q8N6K7	6	130144315-130365425	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 10.4"	"Group enriched"	"Detected in many"	5	"NK-cells: 253.7;T-cells: 72.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	47	"NK-cells: 128.4;T-cells: 113.8"	"Low cancer specificity"	"Detected in some"			"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Heart muscle - T-cells, Kidney - T-cells, Liver - NK-cells (Liver), Lung - NK-cells (Lung), Pancreas - Alpha cells, Prostate - T-cells, Testis - Early spermatids, Thyroid - T-cells"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"cerebellum: 2.1"	"HPA028992, HPA028993"	Uncertain					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 20: Connective tissue cells - ECM organization"	"Cluster 7: NK-cells - Immune response regulation"			"HPA028992: AB_10598914, HPA028993: AB_10601891"	"unprognostic (2.91e-3)"	"unprognostic (5.35e-3)"	"unprognostic (4.15e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.48e-4)"	"unprognostic (1.20e-2)"	"unprognostic (2.42e-3)"	"unprognostic (2.39e-2)"	"unprognostic (2.46e-2)"	"unprognostic (5.61e-2)"	"unprognostic (1.98e-1)"	"unprognostic (5.07e-6)"	"unprognostic (7.09e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.62e-2)"	"unprognostic (3.45e-2)"
SH2D2A	"F2771, TSAd"	ENSG00000027869	"SH2 domain containing 2A"	Q9NP31	1	156806243-156816848	"Predicted intracellular proteins"	"Angiogenesis, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 14.9"	"Group enriched"	"Detected in many"	4	"NK-cells: 203.0;T-cells: 93.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	30	"NK-cells: 28.5;T-cells: 66.5"	"Group enriched"	"Detected in many"	6	"Leukemia: 12.8;lymphoma: 31.9;Myeloma: 12.0"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Heart muscle - Fibroblasts, Lung - NK-cells (Lung), Skin - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"cerebral cortex: 3.5;hippocampal formation: 1.6"	HPA074482	Enhanced					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 54: Lymphoma - Cytokine signaling"	"Cluster 7: NK-cells - Immune response regulation"			"HPA074482: "	"prognostic favorable (4.96e-4)"	"unprognostic (2.76e-2)"	"unprognostic (7.50e-2)"	"unprognostic (3.03e-3)"	"unprognostic (1.14e-3)"	"unprognostic (2.73e-1)"	"unprognostic (3.11e-1)"	"unprognostic (9.80e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.64e-1)"	"unprognostic (9.34e-3)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (5.26e-12)"	"unprognostic (1.67e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.79e-1)"	"prognostic favorable (1.31e-4)"
SLA2	"C20orf156, FLJ21992, SLAP-2"	ENSG00000101082	"Src like adaptor 2"	Q9H6Q3	20	36612318-36646196	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 12.5;lymphoid tissue: 18.3"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 29.1;NK-cells: 133.2;T-cells: 52.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	6	"gdT-cell: 28.8;MAIT T-cell: 24.1;memory CD4 T-cell: 23.8;memory CD8 T-cell: 27.1;naive CD4 T-cell: 21.8;naive CD8 T-cell: 30.5;NK-cell: 39.2;plasmacytoid DC: 48.5;T-reg: 33.4"	"Group enriched"	"Detected in many"	8	"dendritic cells: 48.5;NK-cells: 39.2;T-cells: 33.4"	"Cancer enriched"	"Detected in some"	8	"Leukemia: 14.9"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Kidney - T-cells, Lung - NK-cells (Lung), Prostate - T-cells, Skin - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"							"HPA053746, HPA058217"			Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		No	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 32: Myeloid leukemia - Oxygen transport"	"Cluster 7: NK-cells - Immune response regulation"	"Nucleoplasm, Golgi apparatus, Vesicles"		"HPA053746: AB_2682246, HPA058217: AB_2683641"	"unprognostic (4.16e-3)"	"prognostic favorable (7.36e-4)"	"unprognostic (4.52e-4)"	"unprognostic (2.30e-6)"	"unprognostic (3.37e-2)"	"unprognostic (3.79e-3)"	"unprognostic (2.15e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.22e-3)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (6.77e-8)"	"unprognostic (8.48e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.98e-2)"	"unprognostic (6.45e-3)"
TKTL1	"TKR, TKT2"	ENSG00000007350	"Transketolase like 1"	P51854	X	154295795-154330350	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	29	"testis: 127.1"	"Group enriched"	"Detected in some"	7	"Spermatocytes: 236.6;Spermatogonia: 456.0"	"Cancer enriched"	"Detected in many"	8	"testis cancer: 44.2"	"Group enriched"	"Detected in some"	5	"cerebral cortex: 4.3;medulla oblongata: 1.7"	"Group enriched"	"Detected in many"	5	"eosinophil: 60.9;gdT-cell: 24.4"	"Group enriched"	"Detected in many"	5	"granulocytes: 60.9;T-cells: 24.4"	"Cancer enhanced"	"Detected in some"		"Gallbladder cancer: 11.0;Myeloma: 7.2"	"Heart muscle - Cardiomyocytes, Lung - NK-cells (Lung), Testis - Spermatocytes, Testis - Spermatogonia"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"white matter: 1.2"	"HPA000505, HPA029155, CAB032191"	Enhanced		Enhanced	Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 74: Testis - Spermatogenesis"	"Cluster 44: Myeloma - Humoral immune response"	"Cluster 47: Spermatogonia - Spermatogenesis"	Cytosol		"CAB032191: , HPA000505: AB_1858022, HPA029155: AB_10603134"	"unprognostic (2.69e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.98e-1)"	"unprognostic (5.80e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.90e-2)"	"unprognostic (5.04e-2)"	"unprognostic (2.38e-1)"
TMEM71	FLJ33069	ENSG00000165071	"Transmembrane protein 71"	Q6P5X7	8	132685007-132760712	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 33.5;heart muscle: 37.1"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 19.8;Kupffer cells: 31.5;Langerhans cells: 34.5;Macrophages: 23.2;monocytes: 20.0;NK-cells: 66.7;Schwann cells: 21.6;T-cells: 34.8"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	4	"cerebral cortex: 9.7"	"Immune cell enhanced"	"Detected in all"		"neutrophil: 269.0"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 269.0"	"Cancer enhanced"	"Detected in many"		"Bone cancer: 9.7;Leukemia: 8.4"	"Colon - Enteric glia cells, Kidney - T-cells, Lung - NK-cells (Lung)"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA058401, HPA070655"	Uncertain		Enhanced	Mitochondria		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 66: Myeloid cells - Innate immune response"	"Cluster 7: NK-cells - Immune response regulation"	Mitochondria		"HPA058401: AB_2683707, HPA070655: AB_2686292"	"unprognostic (1.39e-3)"	"unprognostic (7.27e-2)"	"unprognostic (8.82e-2)"	"unprognostic (3.10e-3)"	"unprognostic (7.94e-2)"	"unprognostic (3.91e-3)"	"unprognostic (4.18e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.62e-1)"	"unprognostic (8.83e-2)"	"unprognostic (1.90e-2)"	"unprognostic (6.29e-3)"	"unprognostic (4.39e-2)"	"unprognostic (2.73e-1)"
TRDC		ENSG00000211829	"T cell receptor delta constant"		14	22462932-22465787	"Predicted membrane proteins, T-cell receptor genes"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in many"	15	"lymphoid tissue: 404.4"	"Group enriched"	"Detected in some"	11	"NK-cells: 474.1;T-cells: 132.5"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 19.6"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	87	"gdT-cell: 5873.4;NK-cell: 2243.9"	"Group enriched"	"Detected in all"	150	"NK-cells: 2243.9;T-cells: 5873.4"	"Cancer enhanced"	"Detected in some"		"breast cancer: 18.7;Leukemia: 53.7"	"Heart muscle - T-cells, Liver - NK-cells (Liver), Lung - NK-cells (Lung), Thyroid - T-cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 2: DU4475 - Unknown function"	"Cluster 7: NK-cells - Immune response regulation"				"unprognostic (1.21e-3)"	"unprognostic (8.15e-3)"	"unprognostic (7.03e-2)"	"prognostic favorable (8.25e-4)"	"unprognostic (2.53e-1)"	"unprognostic (2.42e-3)"	"unprognostic (2.19e-1)"	"prognostic favorable (6.13e-4)"	"unprognostic (2.76e-2)"	"unprognostic (2.19e-2)"	"unprognostic (4.94e-2)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (7.67e-5)"	"unprognostic (1.25e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.99e-2)"
TRGC1	"C1, TCRGC1"	ENSG00000211689	"T cell receptor gamma constant 1"		7	38257879-38265678	"Predicted membrane proteins, T-cell receptor genes"				"Evidence at transcript level"	"Evidence at transcript level"			"Group enriched"	"Detected in some"	8	"bone marrow: 31.7;prostate: 76.6"	"Group enriched"	"Detected in some"	14	"NK-cells: 195.1;Prostatic glandular cells: 166.2;T-cells: 67.7"	"Cancer enriched"	"Detected in some"	141	"prostate cancer: 107.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"gdT-cell: 384.7"	"Lineage enriched"	"Detected in many"	4	"T-cells: 384.7"	"Cancer enriched"	"Detected in some"	6	"prostate cancer: 52.2"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Heart muscle - T-cells, Lung - NK-cells (Lung), Prostate - Prostate glandular cells, Thyroid - T-cells"															NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 24: Prostate cancer - Lipid metabolism"	"Cluster 7: NK-cells - Immune response regulation"				"unprognostic (2.37e-2)"	"unprognostic (2.38e-4)"	"unprognostic (3.43e-3)"	"unprognostic (6.04e-4)"	"unprognostic (1.04e-2)"	"unprognostic (3.77e-3)"	"unprognostic (1.33e-3)"	"unprognostic (3.80e-2)"	"unprognostic (3.55e-2)"	"unprognostic (3.33e-3)"	"unprognostic (2.82e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.98e-1)"	"unprognostic (8.36e-2)"	"unprognostic (2.56e-2)"
TRGV10	"TCRGV10, V3P"	ENSG00000211694	"T cell receptor gamma variable 10 (non-functional)"		7	38299811-38300322	"Predicted intracellular proteins, T-cell receptor genes"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 14.1;lymphoid tissue: 13.9"	"Cell type enriched"	"Detected in some"	4	"T-cells: 27.0"	"Cancer enriched"	"Detected in many"	8	"prostate cancer: 7.3"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 196.5"	"Lineage enriched"	"Detected in many"	8	"T-cells: 196.5"	"Group enriched"	"Detected in some"	6	"Leukemia: 5.2;prostate cancer: 1.8"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Kidney - T-cells, Lung - NK-cells (Lung), Thyroid - T-cells"															NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 66: Myeloid cells - Innate immune response"	"Cluster 2: T-cells - T-cell receptor"				"unprognostic (1.59e-2)"	"unprognostic (4.53e-3)"	"unprognostic (5.13e-2)"	"unprognostic (2.94e-3)"	"unprognostic (1.54e-2)"	"unprognostic (1.22e-4)"	"unprognostic (2.47e-3)"	"unprognostic (2.24e-1)"	"unprognostic (2.50e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.24e-4)"	"unprognostic (2.68e-1)"	"unprognostic (9.00e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.07e-2)"